Cargando…

Enhanced NSAIDs Solubility in Drug–Drug Formulations with Ciprofloxacin †

Drug–drug salts are a kind of pharmaceutical multicomponent solid in which the two co-existing components are active pharmaceutical ingredients (APIs) in their ionized forms. This novel approach has attracted great interest in the pharmaceutical industry since it not only allows concomitant formulat...

Descripción completa

Detalles Bibliográficos
Autores principales: Acebedo-Martínez, Francisco Javier, Domínguez-Martín, Alicia, Alarcón-Payer, Carolina, Sevillano-Páez, Alejandro, Verdugo-Escamilla, Cristóbal, González-Pérez, Josefa María, Martínez-Checa, Fernando, Choquesillo-Lazarte, Duane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964002/
https://www.ncbi.nlm.nih.gov/pubmed/36834716
http://dx.doi.org/10.3390/ijms24043305
_version_ 1784896395087446016
author Acebedo-Martínez, Francisco Javier
Domínguez-Martín, Alicia
Alarcón-Payer, Carolina
Sevillano-Páez, Alejandro
Verdugo-Escamilla, Cristóbal
González-Pérez, Josefa María
Martínez-Checa, Fernando
Choquesillo-Lazarte, Duane
author_facet Acebedo-Martínez, Francisco Javier
Domínguez-Martín, Alicia
Alarcón-Payer, Carolina
Sevillano-Páez, Alejandro
Verdugo-Escamilla, Cristóbal
González-Pérez, Josefa María
Martínez-Checa, Fernando
Choquesillo-Lazarte, Duane
author_sort Acebedo-Martínez, Francisco Javier
collection PubMed
description Drug–drug salts are a kind of pharmaceutical multicomponent solid in which the two co-existing components are active pharmaceutical ingredients (APIs) in their ionized forms. This novel approach has attracted great interest in the pharmaceutical industry since it not only allows concomitant formulations but also has proved potential to improve the pharmacokinetics of the involved APIs. This is especially interesting for those APIs that have relevant dose-dependent secondary effects, such as non-steroidal anti-inflammatory drugs (NSAIDs). In this work, six multidrug salts involving six different NSAIDs and the antibiotic ciprofloxacin are reported. The novel solids were synthesized using mechanochemical methods and comprehensively characterized in the solid state. Moreover, solubility and stability studies, as well as bacterial inhibition assays, were performed. Our results suggest that our drug–drug formulations enhanced the solubility of NSAIDs without affecting the antibiotic efficacy.
format Online
Article
Text
id pubmed-9964002
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-99640022023-02-26 Enhanced NSAIDs Solubility in Drug–Drug Formulations with Ciprofloxacin † Acebedo-Martínez, Francisco Javier Domínguez-Martín, Alicia Alarcón-Payer, Carolina Sevillano-Páez, Alejandro Verdugo-Escamilla, Cristóbal González-Pérez, Josefa María Martínez-Checa, Fernando Choquesillo-Lazarte, Duane Int J Mol Sci Article Drug–drug salts are a kind of pharmaceutical multicomponent solid in which the two co-existing components are active pharmaceutical ingredients (APIs) in their ionized forms. This novel approach has attracted great interest in the pharmaceutical industry since it not only allows concomitant formulations but also has proved potential to improve the pharmacokinetics of the involved APIs. This is especially interesting for those APIs that have relevant dose-dependent secondary effects, such as non-steroidal anti-inflammatory drugs (NSAIDs). In this work, six multidrug salts involving six different NSAIDs and the antibiotic ciprofloxacin are reported. The novel solids were synthesized using mechanochemical methods and comprehensively characterized in the solid state. Moreover, solubility and stability studies, as well as bacterial inhibition assays, were performed. Our results suggest that our drug–drug formulations enhanced the solubility of NSAIDs without affecting the antibiotic efficacy. MDPI 2023-02-07 /pmc/articles/PMC9964002/ /pubmed/36834716 http://dx.doi.org/10.3390/ijms24043305 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Acebedo-Martínez, Francisco Javier
Domínguez-Martín, Alicia
Alarcón-Payer, Carolina
Sevillano-Páez, Alejandro
Verdugo-Escamilla, Cristóbal
González-Pérez, Josefa María
Martínez-Checa, Fernando
Choquesillo-Lazarte, Duane
Enhanced NSAIDs Solubility in Drug–Drug Formulations with Ciprofloxacin †
title Enhanced NSAIDs Solubility in Drug–Drug Formulations with Ciprofloxacin †
title_full Enhanced NSAIDs Solubility in Drug–Drug Formulations with Ciprofloxacin †
title_fullStr Enhanced NSAIDs Solubility in Drug–Drug Formulations with Ciprofloxacin †
title_full_unstemmed Enhanced NSAIDs Solubility in Drug–Drug Formulations with Ciprofloxacin †
title_short Enhanced NSAIDs Solubility in Drug–Drug Formulations with Ciprofloxacin †
title_sort enhanced nsaids solubility in drug–drug formulations with ciprofloxacin †
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964002/
https://www.ncbi.nlm.nih.gov/pubmed/36834716
http://dx.doi.org/10.3390/ijms24043305
work_keys_str_mv AT acebedomartinezfranciscojavier enhancednsaidssolubilityindrugdrugformulationswithciprofloxacin
AT dominguezmartinalicia enhancednsaidssolubilityindrugdrugformulationswithciprofloxacin
AT alarconpayercarolina enhancednsaidssolubilityindrugdrugformulationswithciprofloxacin
AT sevillanopaezalejandro enhancednsaidssolubilityindrugdrugformulationswithciprofloxacin
AT verdugoescamillacristobal enhancednsaidssolubilityindrugdrugformulationswithciprofloxacin
AT gonzalezperezjosefamaria enhancednsaidssolubilityindrugdrugformulationswithciprofloxacin
AT martinezchecafernando enhancednsaidssolubilityindrugdrugformulationswithciprofloxacin
AT choquesillolazarteduane enhancednsaidssolubilityindrugdrugformulationswithciprofloxacin